1. Home
  2. CTXR vs PETZ Comparison

CTXR vs PETZ Comparison

Compare CTXR & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

SELL

Current Price

$0.51

Market Cap

13.4M

Sector

Health Care

ML Signal

SELL

Logo TDH Holdings Inc.

PETZ

TDH Holdings Inc.

N/A

Current Price

$1.05

Market Cap

11.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CTXR
PETZ
Founded
2007
2002
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
11.4M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
CTXR
PETZ
Price
$0.51
$1.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 253.3K
3.3K
Earning Date
12-22-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.38
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$104.18
N/A
P/E Ratio
★ N/A
$6.89
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.81
52 Week High
$1.54
$1.83

Technical Indicators

Market Signals
Indicator
CTXR
PETZ
Relative Strength Index (RSI) 48.05 35.31
Support Level $0.47 $0.98
Resistance Level $0.63 $1.38
Average True Range (ATR) 0.06 0.06
MACD -0.00 -0.01
Stochastic Oscillator 22.42 0.00

Price Performance

Historical Comparison
CTXR
PETZ

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About PETZ TDH Holdings Inc.

TDH Holdings Inc currently focus on commercial real estate management. The company has determined that it has only one operating segment which is commercial real estate leasing operations. The company has presence in China and United States of which majority of revenue comes from China.

Share on Social Networks: